000 01591 a2200397 4500
005 20250515204909.0
264 0 _c20100301
008 201003s 0 0 eng d
022 _a1555-2101
024 7 _a10.4088/JCP.09l05388
_2doi
040 _aNLM
_beng
_cNLM
100 1 _ade Lucena, David
245 0 0 _aLack of association between serum brain-derived neurotrophic factor levels and improvement of schizophrenia symptoms in a double-blind, randomized, placebo-controlled trial of memantine as adjunctive therapy to clozapine.
_h[electronic resource]
260 _bThe Journal of clinical psychiatry
_cJan 2010
300 _a91-2 p.
_bdigital
500 _aPublication Type: Letter; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAntipsychotic Agents
_xtherapeutic use
650 0 4 _aBrain-Derived Neurotrophic Factor
_xblood
650 0 4 _aClozapine
_xtherapeutic use
650 0 4 _aDopamine Agents
_xtherapeutic use
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Therapy, Combination
650 0 4 _aHumans
650 0 4 _aMemantine
_xtherapeutic use
650 0 4 _aSchizophrenia
_xblood
650 0 4 _aTreatment Outcome
700 1 _aFernandes, Brisa Simões
700 1 _aKunz, Mauricio
700 1 _aFries, Gabriel Rodrigo
700 1 _aStertz, Laura
700 1 _aAguiar, Bianca
700 1 _aPfaffenseller, Bianca
700 1 _aGama, Clarissa Severino
773 0 _tThe Journal of clinical psychiatry
_gvol. 71
_gno. 1
_gp. 91-2
856 4 0 _uhttps://doi.org/10.4088/JCP.09l05388
_zAvailable from publisher's website
999 _c19500949
_d19500949